
Fighting inflammation: Keli’s stem cell approach seeks to tackle myriad of conditions
Cell and gene therapy (CGT) company Keli Therapeutics is seeking to change how inflammatory conditions are treated, claiming that its pipelines of mesenchymal stromal cell (MSC) therapies can be used for a wide range of diseases. But what makes Keli’s …